meta_pixel
Tapesearch Logo
Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Mechanisms of Drug Interactions Episode 313

Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist

Education, Health & Fitness, Medicine

5 • 716 Ratings

🗓️ 8 February 2024

⏱️ 20 minutes

🧾️ Download transcript

Summary

On this episode of the Real Life Pharmacology podcast, I take a dive into the most common mechanisms of drug interactions. Below I list some of the common drug interactions seen in practice and how they work!



Opposing Effects



Many drugs will work on various receptors throughout the body. To use as an educational point, there is no better example to point to than the beta receptor. Beta-blockers are frequently used in clinical practice for their ability to lower blood pressure and slow the heart rate. Both of these beneficial actions are primarily achieved by blocking the effects of beta-1 receptors.



Some beta-blockers have action on alternative beta receptors. Propranolol is one such beta-blocker that is classified as a non-selective beta-blockers. This means that in addition to the positive effects on beta-1 receptors, it can also have blocking effects on beta-2 receptors. The blockade of the beta-2 receptor by propranolol can also be life-changing. It can directly oppose beta-2 agonists like albuterol from having their beneficial effects of opening up the airway.



Enzyme Inhibition



Medication metabolism is arguably the largest and most clinically significant source for drug interactions. Medications that are primarily metabolized by enzymes in the liver can be greatly affected if we affect how those enzymes work. CYP3A4 is one of the most well studied and well-known enzymes that can impact hundreds to maybe even thousands of drugs.



Apixaban is an oral anticoagulant that is broken down at least in part by CYP3A4. By using a CYP3A4 inhibitor like erythromycin, there is the potential to raise concentrations of apixaban. This could lead to a higher risk of bleeding.



Enzyme Induction



Carbamazepine is a drug that you must know. This drug is a potent enzyme inducer. This differs significantly from an enzyme inhibitor and will have the exact opposite clinical effect. Drugs that are inactivated by liver enzymes will be inactivated more quickly in a patient taking an enzyme inducer. Going back to our prior apixaban example above, carbamazepine can induce CYP3A4 and facilitate a more efficient and swifter breakdown of the drug. Bleeding will be less likely. The risk for treatment failure, usually in the form of a blot clot, will be more likely.  Here’s more information from the past on carbamazepine.



Alteration in Absorption



Binding interactions can be consequential and are one of the most common types of drug interactions. Many medications have the potential to bind one another in the gut. This can lead to lower concentrations of a specific medication. Calcium and iron are two of the most common examples of medications that can bind other drugs.



Alteration in Protein Binding



By remembering that unbound drug is an active drug, you should appreciate the risk for protein binding alterations. A significant number of medications can bind proteins in the bloodstream. As this occurs, that drug is not freely available to create physiologic effects. When another medication is added that can also bind these proteins, this can displace other medications and increase the quantity of free drug in the bloodstream. This essentially allows for enhanced physiologic effects.



Warfarin is a medication that is highly protein-bound. When another drug is added that can kick warfarin off of those protein binding sites, it can free up warfarin which will increase the likelihood of elevating the patient’s INR and increase their bleed risk.



Alteration in Renal Elimination



Some drugs can alter the way other medications are eliminated through the kidney.

Transcript

Click on a timestamp to play from that location

0:00.0

Hey all, welcome back to the real life pharmacology podcast. I'm your host, pharmacist, Derek Christensen.

0:05.4

Thank you so much for listening today. As always, go check out real life pharmacology.com. We've got your free 31-page

0:12.2

PDF on the top 200 drugs. Simply an email, we'll get you access to that. So kind of a no-brainer to have.

0:19.6

We also get you updates when we've got new podcasts and other to that. So kind of a no-brainer to have. We also get you updates

0:20.8

when we've got new podcasts and other episodes available. So go check that out at real-life

0:26.7

pharmacology.com. All right, so the drug of the day today is not actually one drug. This is a

0:34.3

unique podcast. By request, somebody asked me to kind of talk a little bit more in

0:40.7

depth about drug interactions. So when I was putting this together, I was trying to figure out

0:47.7

what to do a little bit, because obviously there are thousands of drug interactions, and I'm not

0:53.8

going to cover them all today, of course.

0:57.3

But I've thought a really nice place to start would be mechanisms of drug interactions

1:03.8

because, you know, one drug interaction is definitely not the same as all other drug interactions.

1:11.4

So I wanted to start with some of the most common mechanisms of drug action

1:17.0

and then obviously give you some real-life examples of these.

1:21.8

So without further ado, the first drug interaction is probably one of the more simple ones, and that's binding

1:31.2

or absorption kind of blocking interactions. Common examples here, so you've got calcium that can bind

1:41.3

up quinolones, quinolone antibiotics, like levofloxysin, for example.

1:47.3

Iron, zinc, they can bind up quinolones as well.

1:53.1

Another antibiotic that can often be bound by some of these metal cations.

1:58.7

Tetracyclines, like doxycycline, tetracycline, that can definitely be bound up in the gut

2:06.2

and absorption blocked. So what that's going to lead to potentially is treatment failure,

2:12.7

where we're not getting adequate concentrations of the drug into the bloodstream to do its effects.

...

Transcript will be available on the free plan in -418 days. Upgrade to see the full transcript now.

Disclaimer: The podcast and artwork embedded on this page are from Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.